GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Future 3-5Y EPS without NRI Growth Rate

IPDQF (Impedimed) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 09, 2025)


View and export this data going back to . Start your Free Trial

What is Impedimed Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Impedimed's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of Impedimed's Future 3-5Y EPS without NRI Growth Rate

For the Medical Devices subindustry, Impedimed's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Impedimed's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Impedimed's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Impedimed's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Impedimed  (OTCPK:IPDQF) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Impedimed Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Impedimed's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Impedimed Business Description

Industry
Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

From GuruFocus

Q3 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2024 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 09-14-2024

Q1 2021 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2020 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Limited - Special Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Ordinary Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Half Year 2024 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 09-14-2024

Q3 2024 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 09-14-2024

Q2 2024 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 09-14-2024